3D profile gene data
|
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
---|
1
|
BTK
|
ECSIT
|
IKBKB
|
IRF3
|
MYD88
|
RELA
|
TLR3
|
ACTB
|
0.64
|
0.86
|
0.88
|
0.84
|
1.63
|
1.17
|
1.39
|
1.14
|
2
|
CASP8
|
EIF2AK2
|
IL10
|
JUN
|
NFKB1
|
RIPK2
|
TLR4
|
B2M
|
0.86
|
1.16
|
0.41
|
0.75
|
1.77
|
1.06
|
0.74
|
1.16
|
3
|
CCL2
|
ELK1
|
IL12A
|
LTA
|
NFKB2
|
SARM1
|
TLR5
|
GAPDH
|
13.80
|
0.85
|
1.35
|
0.91
|
0.41
|
0.81
|
1.71
|
0.87
|
4
|
CD14
|
FADD
|
IL1A
|
LY86
|
NFKBIA
|
SIGIRR
|
TLR6
|
HPRT1
|
1.00
|
0.91
|
0.60
|
0.82
|
3.01
|
1.19
|
0.68
|
1.09
|
5
|
CD180
|
FOS
|
IL1B
|
LY96
|
NFKBIL1
|
TAB1
|
TLR7
|
RPLPO
|
2.57
|
1.18
|
12.43
|
1.02
|
0.27
|
0.83
|
7.73
|
0.79
|
6
|
CD80
|
HMGB1
|
IL2
|
MAP2K3
|
NFRKB
|
TBK1
|
TLR8
| |
2.57
|
0.65
|
0.82
|
1.10
|
0.86
|
0.71
|
0.55
|
7
|
CD86
|
HRAS
|
IL6
|
MAP2K4
|
NR2C2
|
TICAM1
|
TLR9
| |
0.82
|
0.27
|
21.55
|
0.95
|
0.85
|
1.58
|
0.71
|
8
|
CHUK
|
HSP1A1
|
IL8
|
MAP3K1
|
PELT1
|
TICAM2
|
TNF
| |
1.01
|
1.12
|
19.37
|
0.89
|
1.23
|
0.75
|
2.50
|
9
|
CLEC4E
|
HSPD1
|
IRAK1
|
MAP3K7
|
PPARA
|
TIRAP
|
TNFRSF1A
| |
0.82
|
0.82
|
0.91
|
0.96
|
0.79
|
0.88
|
1.07
|
10
|
CSF2
|
IFNA1
|
IRAK2
|
MAP4K4
|
PRKRA
|
TLR1
|
TOLLIP
| |
9.57
|
0.89
|
1.79
|
0.87
|
1.03
|
0.48
|
1.58
|
11
|
CSF3
|
IFNB1
|
IRAK4
|
MAPK8
|
PTGS2
|
TLR10
|
TRAF6
| |
43.95
|
1.42
|
1.58
|
0.86
|
4.75
|
0.30
|
0.91
|
12
|
CXCL10
|
IFNG
|
IRF1
|
MAPK8IP3
|
REL
|
TLR2
|
UBE2N
| |
217.01
|
0.82
|
2.03
|
0.74
|
1.19
|
5.64
|
0.94
|
- MSCs were treated with or without 200 μg/ml A549 cell-derived exosomes for 24 h. Total RNA were analyzed using human toll-like receptor signaling pathway array. Fold change of RNA expression was used for 3D profile (200–24 h/0–24 h)